drugset / Trial / NCT01239173

Emotional Memory Reactivation in Posttraumatic Stress Disorder

NCT01239173

Phase 3 Terminated 5 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedFactorialQuadruple-blindTreatment

Summary

Converging lines of evidence have implicated the amygdala in the pathophysiology of posttraumatic stress disorder. The primary purpose of our study is to assess the effect of propanolol, a beta adrenergic antagonism, on amygdala activation during a symptom provocation state in traumatized subjects with and without posttraumatic stress disorder.

Timeline

Start
2010-09
Primary completion
2011-11
Completion
2012-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 40 mg